Key result
Pituitary adrenocorticotropic hormone (ACTH) use in poliomyelitis is discussed in the context of host susceptibility and nonspecific defensive mechanisms, with no quantitative results reported.
Authors
Loading...
Should not change poliomyelitis management; leaves open ACTH effects on host susceptibility for prospective study.
L.L. Coriell (1950) conducted a review in Poliomyelitis. Pituitary adrenocorticotropic hormone (ACTH) was evaluated. Pituitary adrenocorticotropic hormone (ACTH) use in poliomyelitis is discussed in the context of host susceptibility and nonspecific defensive mechanisms, with no quantitative results reported.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: